Circulating tumor DNA may be a prognostic biomarker for relapse and early recurrence detection in resected early-stage ...
Preliminary trial results demonstrated that Imfinzi plus chemo improved event-free survival in resectable early-stage gastric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback